QHSLab, Inc. Files Q1 2025 10-Q

Ticker: USAQ · Form: 10-Q · Filed: May 14, 2025 · CIK: 856984

Sentiment: neutral

Topics: 10-Q, financials, quarterly-report

TL;DR

QHSLab filed its Q1 2025 10-Q. Financials are in.

AI Summary

QHSLab, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance sheet items and statements of operations. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This filing provides investors with an update on QHSLab, Inc.'s financial performance and position as of March 31, 2025, crucial for understanding the company's operational health.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is March 31, 2025.

When was this 10-Q filed with the SEC?

This 10-Q was filed on May 14, 2025.

What is QHSLab, Inc.'s Standard Industrial Classification code?

QHSLab, Inc.'s SIC code is 3841, for Surgical & Medical Instruments & Apparatus.

What were some of QHSLab, Inc.'s former company names?

QHSLab, Inc. was formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.

In which state is QHSLab, Inc. incorporated?

QHSLab, Inc. is incorporated in Nevada (NV).

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding QHSLab, Inc. (USAQ).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing